Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Oncotarget
|
November 29, 2016
Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surface
Xiaoying Ye, King C Chan, Andrew M Waters, et al.
Science Signaling
|
September 28, 2017
Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies
Andrew M Waters, Irem Ozkan-Dagliyan, Angelina V Vaseva, et al.
Biorxiv : the Preprint Server for Biology
|
May 4, 2026
Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer
Wen-Hsuan Chang, Alec J Vaughan, Addison G Stamey, et al.
NPJ Precision Oncology
|
May 31, 2024
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers
Daniel P Nussbaum, Colin A Martz, Andrew M Waters, et al.
Science Signaling
|
August 9, 2022
Functional and biological heterogeneity of KRAS<sup>Q61</sup> mutations
Minh V Huynh, G Aaron Hobbs, Antje Schaefer, et al.
Cancer Research
|
November 8, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer
Craig M Goodwin, Andrew M Waters, Jennifer E Klomp, et al.
Cancer Research
|
November 17, 2025
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer
Szu-Aun Long, Haley Todd, Grace Goodhart, et al.
Cell Reports
|
June 20, 2020
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
Irem Ozkan-Dagliyan, J Nathaniel Diehl, Samuel D George, et al.
Cell Reports
|
February 15, 2018
Differential Effector Engagement by Oncogenic KRAS
Tina L Yuan, Arnaud Amzallag, Rachel Bagni, et al.
Cancer Research
|
November 5, 2021
Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth
Danielle R Cook, Melissa Kang, Timothy D Martin, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Oncotarget
|
November 29, 2016
Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surface
Xiaoying Ye, King C Chan, Andrew M Waters, et al.
Science Signaling
|
September 28, 2017
Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies
Andrew M Waters, Irem Ozkan-Dagliyan, Angelina V Vaseva, et al.
Biorxiv : the Preprint Server for Biology
|
May 4, 2026
Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer
Wen-Hsuan Chang, Alec J Vaughan, Addison G Stamey, et al.
NPJ Precision Oncology
|
May 31, 2024
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers
Daniel P Nussbaum, Colin A Martz, Andrew M Waters, et al.
Science Signaling
|
August 9, 2022
Functional and biological heterogeneity of KRAS<sup>Q61</sup> mutations
Minh V Huynh, G Aaron Hobbs, Antje Schaefer, et al.
Cancer Research
|
November 8, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer
Craig M Goodwin, Andrew M Waters, Jennifer E Klomp, et al.
Cancer Research
|
November 17, 2025
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer
Szu-Aun Long, Haley Todd, Grace Goodhart, et al.
Cell Reports
|
June 20, 2020
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
Irem Ozkan-Dagliyan, J Nathaniel Diehl, Samuel D George, et al.
Cell Reports
|
February 15, 2018
Differential Effector Engagement by Oncogenic KRAS
Tina L Yuan, Arnaud Amzallag, Rachel Bagni, et al.
Cancer Research
|
November 5, 2021
Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth
Danielle R Cook, Melissa Kang, Timothy D Martin, et al.
Page
of 3